Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/3/24 17:38 | 8/29/24 | QNCX | Health | BioPrd | Biological Products, (No Diag | Thye Dirk | CA | DO | CEO,CHIE | P.m | 107 | 0.6950 | 0 | 155 | 22 | 844 | D | ||||||||||||||
8/22/24 17:51 | 8/20/24 | QNCX | Health | BioPrd | Biological Products, (No Diag | Ryan Charles S. | CA | O | P | P | 31 | 0.6500 | 0 | 48 | 65 | 122 | D | ||||||||||||||
8/21/24 18:38 | 8/19/24 | QNCX | Health | BioPrd | Biological Products, (No Diag | Hannah Brendan | CA | O | CHIEF BU | P.m | 24 | 0.6209 | 0 | 39 | 15 | 297 | D | ||||||||||||||
12/14/23 18:21 | 12/12/23 | QNCX | Health | BioPrd | Biological Products, (No Diag | Lamond David | CA | D | P.m | 69 | 1.02 | 0 | 68 | 1 | 6,686 | M | |||||||||||||||
12/7/23 18:30 | 12/5/23 | QNCX | Health | BioPrd | Biological Products, (No Diag | Lamond David | CA | D | P.m | 58 | 1.01 | 0 | 57 | 1 | 4,316 | I | |||||||||||||||
12/1/23 13:38 | 11/29/23 | QNCX | Health | BioPrd | Biological Products, (No Diag | Lamond David | CA | D | P.m | 41 | 0.9400 | 0 | 43 | 1 | 4,259 | I | |||||||||||||||
8/31/23 18:42 | 8/30/23 | QNCX | Health | BioPrd | Biological Products, (No Diag | Lamond David | CA | D | P.m | 108 | 1.32 | 0 | 82 | 2 | 4,216 | I | |||||||||||||||
8/17/23 18:08 | 8/15/23 | QNCX | Health | BioPrd | Biological Products, (No Diag | Lamond David | CA | D | P.m | 326 | 1.30 | 0 | 250 | 6 | 4,134 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |